CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-30 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −2,163 | $143.49 | $310K | 8,000 |
| 2021-08-26 | Geshuri Arnnon Chief Human Resources Officer | Sale | −4,050 | $143.29 | $580K | 88,908 |
| 2021-08-25 | Daniel Karen L Director | Option exercise | +6,462 | 41,915 | ||
| 2021-08-25 | Daniel Karen L Director | Option exercise · Restricted Stock Units | −6,462 | 0 | ||
| 2021-08-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 25,486 |
| 2021-08-10 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $152.00 | $304K | 23,486 |
| 2021-08-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 23,430 | ||
| 2021-08-03 | GOREVIC JASON N Chief Executive Officer | Sale | −10,000 | $150.12 | $1.5M | 445,970 |
| 2021-07-30 | Sides David William Chief Operating Officer | Sale | −3,420 | $154.38 | $528K | 11,031 |
| 2021-07-29 | Sides David William Chief Operating Officer | Option exercise | +7,299 | 14,451 | ||
| 2021-07-29 | Sides David William Chief Operating Officer | Option exercise · Restricted Stock Units | −7,299 | 7,299 | ||
| 2021-07-12 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 25,486 |
| 2021-07-12 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $160.30 | $321K | 23,486 |
| 2021-07-12 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 25,430 | ||
| 2021-07-06 | Fenwick Sandra L Director | Sale | −7,173 | $164.63 | $1.2M | 14,349 |
| 2021-07-06 | GOREVIC JASON N Chief Executive Officer | Sale | −1,000 | $161.27 | $161K | 464,970 |
| 2021-07-06 | GOREVIC JASON N Chief Executive Officer | Sale | −4,283 | $162.47 | $696K | 460,687 |
| 2021-07-06 | GOREVIC JASON N Chief Executive Officer | Sale | −3,267 | $163.40 | $534K | 457,420 |
| 2021-07-06 | GOREVIC JASON N Chief Executive Officer | Sale | −1,350 | $164.22 | $222K | 456,070 |
| 2021-07-06 | GOREVIC JASON N Chief Executive Officer | Sale | −100 | $165.15 | $17K | 455,970 |
Page 69 of 93 · 1,848 trades